Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CollPlant Biotechnologies (CLGN)

CollPlant Biotechnologies Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CLGN
DateTimeSourceHeadlineSymbolCompany
04/04/202412:31IH Market NewsUS Index Futures Rise, Oil Dips SlightlyNASDAQ:CLGNCollPlant Biotechnologies Ltd
15/02/202413:19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
15/02/202413:00PR Newswire (US)CollPlant Issues Letter to ShareholdersNASDAQ:CLGNCollPlant Biotechnologies Ltd
25/01/202420:27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CLGNCollPlant Biotechnologies Ltd
02/01/202412:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
29/11/202312:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
01/11/202311:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
10/10/202321:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
22/09/202312:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CLGNCollPlant Biotechnologies Ltd
21/09/202312:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
12/09/202317:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CLGNCollPlant Biotechnologies Ltd
01/09/202321:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
24/08/202312:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
18/07/202321:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
26/06/202312:10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLGNCollPlant Biotechnologies Ltd
14/06/202312:34Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:CLGNCollPlant Biotechnologies Ltd
24/05/202312:05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLGNCollPlant Biotechnologies Ltd
18/04/202321:31Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CLGNCollPlant Biotechnologies Ltd
11/04/202313:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLGNCollPlant Biotechnologies Ltd
04/04/202313:59Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLGNCollPlant Biotechnologies Ltd
04/04/202313:26Business WireStratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and OrgansNASDAQ:CLGNCollPlant Biotechnologies Ltd
29/03/202312:50Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CLGNCollPlant Biotechnologies Ltd
30/01/202319:54Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CLGNCollPlant Biotechnologies Ltd
24/01/202312:00PR Newswire (US)CollPlant Issues Letter to ShareholdersNASDAQ:CLGNCollPlant Biotechnologies Ltd
13/01/202311:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CLGNCollPlant Biotechnologies Ltd
11/01/202313:42Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CLGNCollPlant Biotechnologies Ltd
06/01/202321:31Edgar (US Regulatory)Seperately Filed Delaying Amendment Under Securities Act Rule 473 to Delay Effectiveness of a 1933 Act Registration Statement (del Am)NASDAQ:CLGNCollPlant Biotechnologies Ltd
04/01/202312:06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLGNCollPlant Biotechnologies Ltd
04/01/202312:00PR Newswire (US)CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of ObjectivesNASDAQ:CLGNCollPlant Biotechnologies Ltd
03/01/202312:00PR Newswire (US)CollPlant Enriches Portfolio of rhCollagen-Based Bioinks with Launch of Collink.3DTM 50L in Powder FormNASDAQ:CLGNCollPlant Biotechnologies Ltd
 Showing the most relevant articles for your search:NASDAQ:CLGN